You have read all your free articles, to continue reading subscribe to read the rest of this content.
The financing was led by a group of private investors in Norway and the company will use these funds to advance lead product CyPep-1 into a Phase I clinical trial. Cytovation is developing CyPep-1, a peptide consisting of 27 amino acids that selectively targets cutaneous warts through the destrucAlready a…
Catalyze has opened the doors to their new office at the Copenhagen Bio Science Park (COBIS). From this office, Catalyze, a consulting firm specialized in non-dilutive funding, will be able to better serve its existing and new clients in Medicon Valley and the rest of the Nordics according to thAlready a…
Pelago Bioscience has been awarded a 3.6M SEK Swelife grant to use its patented CETSAâ technique to identify new oncology biomarkers to aid the treatment of childhood leukaemia. Pelago’s CETSA MS format can be used to profile the effect of a drug on up to 6000 proteins. This will be…
Bactiguard and Zimmer Biomet have agreed to expand the global license partnership, that was initiated in 2019, to cover multiple product segments. The extended exclusive license agreement covers implants for joint reconstruction (hips and knees), sports medicine, craniomaxillofacial and thoracic Already a subscriber Login You have read all your free…
